AMLEXANOX Drug Patent Profile
✉ Email this page to a colleague
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMLEXANOX?
- What are the global sales for AMLEXANOX?
- What is Average Wholesale Price for AMLEXANOX?
Summary for AMLEXANOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,607 |
| DailyMed Link: | AMLEXANOX at DailyMed |
Recent Clinical Trials for AMLEXANOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Michigan | Phase 2 |
| Advanced Clinical Research Services, LLC | Phase 2 |
| Access Pharmaceuticals, Inc. | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for AMLEXANOX
US Patents and Regulatory Information for AMLEXANOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uluru | AMLEXANOX | amlexanox | PATCH;TOPICAL | 021727-001 | Sep 29, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
